-- TEPEZZA significantly improved the clinical course of Thyroid Eye Disease (TED) in all patient subgroups, including those with more severe disease at baseline -- -- For patients in the follow-up ...

Viridian Therapeutics' VRDN-001 shows promising data in treating Thyroid Eye Disease (TED), with strong proptosis and diplopia resolution rates, rivaling Amgen's Tepezza. Positive results from Thrive ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Patients who received Tepezza to treat thyroid eye disease showed improved extraocular muscle size ...

-- Additional data from OPTIC 48-week follow-up study and OPTIC-X extension trial, including findings showing that the majority of TEPEZZA patients who were diplopia (double vision) responders in ...

(RTTNews) - Horizon Therapeutics plc (HZNP) said that real-world experience showed Tepezza (teprotumumab-trbw) was effective in treating people with dysthyroid optic neuropathy (DON). Dysthyroid optic ...

Living with a rare disease can often mean days upon months upon years of searching for answers. Unfortunately, this is the case for many who are living with Thyroid Eye Disease (TED) – a rare ...

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data that provide important insights into the mechanisms of TEPEZZA™ (teprotumumab-trbw), illustrating its ...

Tepezza (teprotumumab-trbw) is a brand-name intravenous (IV) infusion for thyroid eye disease in adults. An IV infusion is an injection into a vein given over time. Some of Tepezza’s more common side ...

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (Nasdaq: HZNP) today announced new pooled efficacy data from the Phase 2 and 3 clinical trials of TEPEZZA™ (teprotumumab-trbw) showing that the ...

Tepezza, a medication used to treat thyroid eye disease, may cause side effects. Some can be serious, including hearing loss and high blood sugar. Hearing loss associated with Tepezza can be permanent ...